PDPK1 Gene

Migration, Crosslink

📖

PDPK1 Gene

active

wiki page Created: 2026-04-02T07:19:33 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-pdpk1

📖 Wiki Page

gene2764 wordssynced 2026-04-02

PDPK1 Gene

Overview

PDPK1 (3-Phosphoinositide-Dependent Protein Kinase 1) encodes a serine/threonine kinase that serves as the master activator of the [AKT](/proteins/akt-protein) signaling pathway and other AGC family kinases. PDPK1 is a critical node in [PI3K/AKT signaling](/mechanisms/pi3k-akt-pathway), one of the most important cell survival pathways in the [brain](/brain-regions/overview). This kinase is essential for [neuronal survival](/mechanisms/neuronal-apoptosis), [synaptic plasticity](/mechanisms/synaptic-plasticity), and metabolic regulation. [@pdk2021]

PDPK1 is ubiquitously expressed but shows particularly high expression in [neurons](/cell-types/neurons) of the [hippocampus](/brain-regions/hippocampus) and [cortex](/brain-regions/cortex), regions critically affected in Alzheimer's Disease ([AD](/diseases/alzheimer-disease)) and Parkinson's Disease ([PD](/diseases/parkinson-disease)). The kinase functions as a central signaling hub that integrates inputs from growth factors, neurotrophic factors, and cellular energy status to regulate cell fate decisions. [@akt2023]

Pathway Diagram

...

PDPK1 Gene

Overview

PDPK1 (3-Phosphoinositide-Dependent Protein Kinase 1) encodes a serine/threonine kinase that serves as the master activator of the [AKT](/proteins/akt-protein) signaling pathway and other AGC family kinases. PDPK1 is a critical node in [PI3K/AKT signaling](/mechanisms/pi3k-akt-pathway), one of the most important cell survival pathways in the [brain](/brain-regions/overview). This kinase is essential for [neuronal survival](/mechanisms/neuronal-apoptosis), [synaptic plasticity](/mechanisms/synaptic-plasticity), and metabolic regulation. [@pdk2021]

PDPK1 is ubiquitously expressed but shows particularly high expression in [neurons](/cell-types/neurons) of the [hippocampus](/brain-regions/hippocampus) and [cortex](/brain-regions/cortex), regions critically affected in Alzheimer's Disease ([AD](/diseases/alzheimer-disease)) and Parkinson's Disease ([PD](/diseases/parkinson-disease)). The kinase functions as a central signaling hub that integrates inputs from growth factors, neurotrophic factors, and cellular energy status to regulate cell fate decisions. [@akt2023]

Pathway Diagram

Mermaid diagram (expand to render)

Gene Information

| Property | Value |
|----------|-------|
| Gene Symbol | PDPK1 |
| Full Name | 3-Phosphoinositide Dependent Protein Kinase 1 |
| Aliases | PDK1, PDPK |
| Chromosomal Location | 16p13.3 |
| NCBI Gene ID | [5170](https://www.ncbi.nlm.nih.gov/gene/5170) |
| OMIM | [605363](https://www.omim.org/entry/605363) |
| Ensembl ID | [ENSG00000124151](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000124151) |
| UniProt | [O15530](https://www.uniprot.org/uniprot/O15530) |
| Protein Class | Serine/Threonine Kinase |
| Associated Diseases | [Alzheimer Disease](/diseases/alzheimer-disease), [Parkinson Disease](/diseases/parkinson-disease), Cancer, Diabetes |

</div>

Protein Structure and Mechanism

Domain Architecture

PDPK1 contains several critical structural domains:

PH Domain (Pleckstrin Homology): The N-terminal PH domain binds with high affinity to [PIP3](/proteins/pip3) (phosphatidylinositol-3,4,5-trisphosphate), the product of [PI3K](/proteins/pi3k-catalytic-subunit). This membrane localization is essential for PDPK1 activation. [@pdpk2021]

Kinase Domain: The C-terminal catalytic domain belongs to the AGC kinase family. It contains the activation loop and turn motif that are phosphorylated for full kinase activity. [@stebbings2007]

Docking Motifs: PDPK1 contains PDK1-interacting fragment (PIF) pocket and other docking motifs that enable substrate specificity. Different substrates bind through distinct mechanisms. [@lawlor2012]

Activation Mechanism

PDPK1 activation follows a well-characterized mechanism:

Membrane Recruitment: Following [PI3K](/mechanisms/pi3k-akt-pathway) activation, PIP3 levels increase at the plasma membrane. PDPK1's PH domain binds PIP3, recruiting PDPK1 to the membrane surface. [@maehama2005]

Conformational Change: Membrane binding induces a conformational change that exposes the kinase domain's active site.

Autophosphorylation: PDPK1 undergoes autophosphorylation at Ser241 (turn motif), which is essential for catalytic activity. This phosphorylation is constitutive in most cell types. [@stebbings2007]

Substrate Access: Once activated, PDPK1 can phosphorylate its substrate kinases that are also membrane-localized through their own PH domains.

Substrate Specificity and Downstream Targets

PDPK1 is remarkable for its ability to activate multiple AGC family kinases:

Primary Substrates

| Substrate | Phosphorylation Site | Function |
|-----------|---------------------|----------|
| [AKT1](/proteins/akt-protein) | Thr308 | Full activation, cell survival |
| AKT2 | Thr309 | Metabolic regulation |
| AKT3 | Thr305 | Neuronal-specific function |
| SGK1 | Ser422 | Ion channel regulation |
| PKC isoforms | Various | Signal transduction |
| RSK1 | Ser381 | Translation control |
| PKA | Thr197 | cAMP signaling |

AKT Activation

The most critical function of PDPK1 is the phosphorylation of [AKT](/proteins/akt-protein) at Thr308. This phosphorylation is necessary but not sufficient for full AKT activation; the turn motif (Thr473) must also be phosphorylated, typically by mTORC2. The cooperation between these two phosphorylation events fully activates AKT's kinase activity. [@akt2023]

The PDPK1-mediated AKT activation pathway is frequently dysregulated in neurodegeneration. In [Alzheimer's disease](/diseases/alzheimer-disease), [amyloid-beta](/proteins/amyloid-beta) toxicity leads to impaired [PI3K](/proteins/pi3k-catalytic-subunit) signaling, reducing PDPK1 membrane recruitment and subsequent [AKT](/proteins/akt-protein) activation. This contributes to increased [neuronal apoptosis](/mechanisms/neuronal-apoptosis). [@du2014]

Role in Neuronal Survival

Neurotrophic Factor Signaling

PDPK1 serves as a critical downstream effector of multiple neurotrophic factors:

Brain-Derived Neurotrophic Factor ([BDNF](/proteins/bdnf)): [BDNF](/proteins/bdnf) signaling through TrkB receptors activates [PI3K](/proteins/pi3k-catalytic-subunit), leading to PDPK1 recruitment and [AKT](/proteins/akt-protein) activation. This pathway is essential for [synaptic plasticity](/mechanisms/synaptic-plasticity), [LTP](/mechanisms/long-term-potentiation), and neuronal survival. In AD, BDNF/TrkB signaling is impaired, contributing to synaptic loss. [@akt2023]

Glial Cell Line-Derived Neurotrophic Factor ([GDNF](/proteins/gdnf-protein)): GDNF family ligands signal through GFRα/Ret receptor complexes to activate [PI3K](/proteins/pi3k-catalytic-subunit)/PDPK1/[AKT](/proteins/akt-protein) pathway. This pathway is particularly important for [dopaminergic neuron](/cell-types/dopaminergic-neurons) survival in the [substantia nigra](/brain-regions/substantia-nigra). PDPK1 activity supports dopaminergic neuron survival and may protect against [alpha-synuclein](/proteins/alpha-synuclein)-induced toxicity. [@growth2022]

Anti-Apoptotic Signaling

PDPK1-mediated [AKT](/proteins/akt-protein) activation exerts powerful anti-apoptotic effects through multiple mechanisms:

Bad Phosphorylation: [AKT](/proteins/akt-protein) phosphorylates Bad, displacing it from Bcl-2/Bcl-XL complexes and preventing apoptosis. [@phosphoinositidedependent2022]

Caspase-9 Inhibition: [AKT](/proteins/akt-protein) phosphorylates caspase-9, reducing its activity and blocking the intrinsic apoptosis pathway. [@phosphoinositidedependent2022]

NF-κB Activation: [AKT](/proteins/akt-protein) activates [NF-κB](/proteins/nf-kb), promoting expression of anti-apoptotic genes. [@pdk2021]

Forkhead Transcription Factors: [AKT](/proteins/akt-protein) phosphorylates FoxO transcription factors, excluding them from the nucleus and preventing pro-apoptotic gene expression. [@zhang2017]

In neurons, PDPK1 deficiency leads to increased vulnerability to apoptotic stimuli. Conditional knockouts of PDPK1 in neural progenitor cells result in severe brain malformations due to increased apoptosis during development. [@bayascas2008]

Disease Associations

Alzheimer's Disease

PDPK1 plays a complex role in Alzheimer's disease pathogenesis:

Amyloid-Beta Toxicity: [Amyloid-beta](/proteins/amyloid-beta) oligomers impair [PI3K](/proteins/pi3k-catalytic-subunit)/PDPK1/[AKT](/proteins/akt-protein) signaling through multiple mechanisms:

Direct interaction with insulin receptors, reducing PI3K activation
Oxidative stress that damages PI3K signaling components
Membrane lipid alterations that affect PIP3 production

This impairment reduces [AKT](/proteins/akt-protein) activation at Thr308, diminishing pro-survival signaling and contributing to [synaptic loss](/mechanisms/synaptic-loss). [@du2014]

Tau Pathology: The [PI3K](/proteins/pi3k-catalytic-subunit)/PDPK1/[AKT](/proteins/akt-protein)/mTOR pathway regulates [tau](/proteins/tau) phosphorylation through multiple kinases including GSK-3β. Dysregulated PDPK1 signaling contributes to hyperphosphorylation of [tau](/proteins/tau) at AD-relevant epitopes (Ser202, Thr231, Ser396). mTOR overactivation, downstream of PDPK1-AKT, also inhibits autophagy, leading to accumulation of pathological [tau](/proteins/tau) aggregates. [@tandon2022]

Synaptic Dysfunction: PDPK1-mediated [AKT](/proteins/akt-protein) signaling regulates synaptic protein synthesis through mTORC1. In AD, impaired PDPK1 signaling contributes to:

Reduced synaptic plasticity
Impaired memory consolidation
Decreased dendritic spine density [@akt2023]

Parkinson's Disease

PDPDK1 is critical for [dopaminergic neuron](/cell-types/dopaminergic-neurons) survival:

Dopaminergic Neuroprotection: The [GDNF](/proteins/gdnf-protein)-[RET](/proteins/ret-receptor)/[PI3K](/proteins/pi3k-catalytic-subunit)/PDPK1/[AKT](/proteins/akt-protein) pathway provides essential survival signals to [dopaminergic neurons](/cell-types/dopaminergic-neurons) in the [substantia nigra](/brain-regions/substantia-nigra). PDPK1 activity promotes:

Protection against 6-OHDA toxicity
Resistance to [alpha-synuclein](/proteins/alpha-synuclein) aggregation
Mitochondrial integrity maintenance

Genetic or pharmacological inhibition of PDPK1 sensitizes dopaminergic neurons to apoptotic stimuli. [@growth2022]

Alpha-Synuclein Toxicity: [Alpha-synuclein](/proteins/alpha-synuclein) aggregation, the hallmark of [PD](/diseases/parkinson-disease), disrupts cellular signaling pathways including PDPK1/[AKT](/proteins/akt-protein). Soluble [alpha-synuclein](/proteins/alpha-synuclein) oligomers can:

Interact with cellular membranes, affecting PI3K localization
Directly bind and inhibit PDPK1 activity
Induce oxidative stress that impairs kinase signaling

Restoring PDPK1/[AKT](/proteins/akt-protein) signaling is being explored as a neuroprotective strategy in PD models. [@growth2022]

Other Neurological Conditions

Stroke and Ischemia: PDPK1/[AKT](/proteins/akt-protein) signaling is neuroprotective in cerebral ischemia. Pre-conditioning that activates this pathway before stroke provides significant protection. [@phosphoinositidedependent2022]

Huntington's Disease: Mutant huntingtin protein impairs [PI3K](/proteins/pi3k-catalytic-subunit)/PDPK1/[AKT](/proteins/akt-protein) signaling. Enhancing this pathway using small molecule PDPK1 activators has shown promise in cellular models. [@pdk2021]

Amyotrophic Lateral Sclerosis (ALS): Motor neuron survival depends on PDPK1-mediated [AKT](/proteins/akt-protein) activation. Mutations in SOD1 and TDP-43 disrupt this pathway in ALS models. [@phosphoinositidedependent2022]

Autophagy and Protein Clearance

PDPK1/[AKT](/proteins/akt-protein)/mTOR signaling is a major regulator of [autophagy](/mechanisms/autophagy):

mTOR-Dependent Regulation

PDPK1-mediated AKT activation activates mTORC1, which phosphorylates:

ULK1 complex, inhibiting autophagy initiation
TFEB, preventing lysosomal biogenesis
Atg14L, disrupting autophagosome formation

In neurodegeneration, chronic mTOR activation due to dysregulated PDPK1/[AKT](/proteins/akt-protein) signaling contributes to impaired [protein clearance](/mechanisms/protein-quality-control-network), leading to accumulation of [amyloid-beta](/proteins/amyloid-beta), [tau](/proteins/tau), and [alpha-synuclein](/proteins/alpha-synuclein) aggregates. [@han2018]

Therapeutic Implications

Inhibiting mTOR using rapamycin or related compounds can restore autophagy in neurodegenerative conditions. However, chronic mTOR inhibition has adverse effects, making selective modulation of the upstream PDPK1/[AKT](/proteins/akt-protein) pathway an attractive alternative. [@pdk2021]

Therapeutic Targeting

PDPK1 represents a promising therapeutic target for neurodegeneration:

Small Molecule Activators

PDPK1 activators that enhance AKT Thr308 phosphorylation without affecting mTOR are being developed. These would provide neuroprotective signaling while avoiding the immunosuppressive effects of direct mTOR inhibitors. [@pdk2021]

Target Validation

Several approaches validate PDPK1 as a target:

Viral-mediated PDPK1 overexpression in animal models shows neuroprotection
PDPK1 gene therapy approaches in development
Cell-permeable PDPK1 peptides that enhance signaling

Challenges

Systemic PDPK1 modulation affects multiple tissues
Complete loss of PDPK1 is embryonic lethal
Substrate selectivity in the AGC family is challenging
Blood-brain barrier penetration required for CNS therapy

Expression Pattern

PDPK1 shows specific expression patterns in the brain:

| Brain Region | Expression Level | Functional Significance |
|--------------|------------------|------------------------|
| [Hippocampus](/brain-regions/hippocampus) | High | Learning, memory, LTP |
| [Cortex](/brain-regions/cortex) | High | Cognitive function |
| [Substantia Nigra](/brain-regions/substantia-nigra) | Moderate | Dopaminergic neuron survival |
| [Cerebellum](/brain-regions/cerebellum) | Moderate | Motor coordination |
| [Amygdala](/brain-regions/amygdala) | High | Emotional processing |

Expression is highest during development and in areas with active synaptic plasticity. [@phosphoinositidedependent2022]

Interactors and Signaling Network

PDPK1 interacts with numerous proteins in the neuronal signaling network:

Kinases and Phosphatases

[PI3K](/proteins/pi3k-catalytic-subunit) — upstream activator via PIP3 production
[PTEN](/proteins/pten-tumor-suppressor) — negative regulator via PIP3 dephosphorylation
PP2A — dephosphorylates PDPK1 at Ser241
mTORC1/2 — downstream AKT regulation
GSK-3β — interacts with AKT pathway

Adaptors and Scaffolds

PHLDA1 (TAPPH1)
GRB10
IRS proteins
Caveolin-1

Transcription Factors

NF-κB
FoxO family
CREB
HIF-1α

Animal Models

Several mouse models have been developed to study PDPK1 function:

Conditional Knockouts: Neural-specific PDPK1 knockout mice show:

Reduced brain size
Increased apoptosis during development
Impaired learning and memory
Enhanced sensitivity to excitotoxicity

Overexpression Models: PDPK1 overexpression provides:

Protection against amyloid-beta toxicity
Enhanced spatial memory
Increased synaptic density
Resistance to ischemia

Human Studies: PDPK1 polymorphisms have been associated with:

Type 2 diabetes susceptibility
Certain cancer risks
Potential modifier effects in neurodegenerative diseases [@hemmings2021]

Biomarkers and Diagnostics

PDPK1 activity can be assessed through:

Phospho-AKT Thr308 levels (indirect readout)
Phospho-SGK1 levels
Activity assays using synthetic substrates
Imaging using radiolabeled probes (under development)

PDPK1 expression is altered in:

AD patient brains (reduced)
PD patient brains (variable)
Multiple system atrophy (reduced)

Neuroinflammation and Glial Function

PDK1 in Microglia

PDK1 signaling plays a critical role in microglial function and neuroinflammation:

Pro-inflammatory Signaling:

TLR activation triggers PI3K/PDK1/AKT pathway in microglia
PDK1 mediates production of inflammatory cytokines
NF-κB activation downstream of PDK1/AKT promotes inflammation

Anti-inflammatory Functions:

AKT activation can suppress NLRP3 inflammasome
PDK1 contributes to resolution of inflammation
Modulation of microglial polarization states

[@choi2022]

Astrocyte PDK1 Signaling

In astrocytes, PDK1 regulates:

Metabolic support: AKT-mediated glucose uptake for neuron support

Cytokine production: Modulation of inflammatory responses

glutamate clearance: Regulation of EAAT transporters

Blood-brain barrier maintenance: Support of endothelial function

Therapeutic Implications for Neuroinflammation

Targeting PDK1 in glia offers therapeutic potential:

Inhibiting excessive inflammation: Modulating microglial activation
Supporting astrocyte function: Enhancing metabolic coupling
Combination approaches: With anti-amyloid or anti-tau therapies

Mitochondrial Dynamics and Energy Metabolism

PDK1 Regulation of Mitochondrial Function

PDPK1/AKT signaling directly influences mitochondrial dynamics:

Fusion and Fission:

AKT phosphorylates DRP1, regulating mitochondrial fission
PDK1 activity affects OPA1-mediated fusion
Balance between fusion/fission impacts neuronal survival

[@li2020]

Mitochondrial Quality Control:

PDK1/AKT/mTOR pathway regulates mitophagy
PINK1/Parkin recruitment influenced by AKT signaling
Impaired mitophagy contributes to neurodegeneration

Bioenergetics in Neurodegeneration

PDK1 supports neuronal bioenergetics:

ATP production: AKT enhances glycolytic and oxidative metabolism

Calcium handling: Mitochondrial calcium uptake regulated by AKT

mtDNA maintenance: AKT supports mitochondrial DNA replication

Oxidative stress: Modulation of antioxidant gene expression

Neuronal Excitability and Epilepsy

PDK1 in Ion Channel Regulation

PDPK1/AKT signaling modulates neuronal excitability:

Voltage-gated ion channels:

AKT regulates sodium channel trafficking
Modulates calcium channel function
Affects potassium channel activity

Ligand-gated receptors:

NMDA receptor phosphorylation by AKT
GABA receptor modulation
AMPA receptor trafficking

[@martinez2021]

Epilepsy Implications

PDK1 dysregulation contributes to epileptogenesis:

Seizure-induced changes: PDK1 activity altered in seizure foci
Network hyperexcitability: Impaired AKT signaling affects inhibition
Therapeutic targeting: PDK1 modulators may reduce seizure frequency

Axonal Transport and Synaptic Function

PDK1 in Axonal Trafficking

PDPK1/AKT regulates intracellular transport:

Motor Protein Regulation:

AKT phosphorylates kinesin light chains
Affects dynein function
Modulates cargo selection

Synaptic Organelle Transport:

Mitochondria trafficking in axons
Synaptic vesicle precursor transport
Endocytic trafficking pathways

[@yang2019]

Synaptic Homeostasis

PDK1 maintains synaptic function:

Presynaptic function: Regulates vesicle cycling

Postsynaptic signaling: Modulates receptor insertion

Spine morphology: Controls actin dynamics

plasticity: Supports LTP and LTD

Structural Biology and Drug Discovery

PDK1 Kinase Domain Structure

The PDPK1 kinase domain has unique features:

Active Site Architecture:

Classic kinase fold with additional regulatory features
Ser/Thr specificity with preference for hydrophobic residues
Unique activation segment conformation

[@xu2022]

Selective Inhibitor Development

Developing selective PDK1 modulators:

| Strategy | Approach | Challenges |
|----------|----------|------------|
| ATP-competitive | Bind active site | Selectivity over AGC kinases |
| Allosteric | Target regulatory sites | Brain penetration |
| PROTAC | Induce degradation | Efficient delivery |

Isoform-Specific Functions

PDPK1 vs PDPK2

The PDPK family has distinct isoforms:

| Feature | PDPK1 | PDPK2 |
|--------|-------|-------|
| Expression | Ubiquitous, high in brain | Tissue-restricted |
| Substrate preference | AKT, SGK, PKC | More restricted |
| Regulatory features | PIF pocket | Different regulation |
| Knockout phenotype | Embryonic lethal | Viable with defects |

[@chen2021]

Isoform-Selective Targeting

Therapeutic strategies consider isoform selectivity:

Brain-penetrant PDPK1-selective compounds
Isoform-specific antibodies
RNA-based approaches targeting specific isoforms

PDK1 in Neural Stem Cells and Development

Neural Stem Cell Biology

PDPK1 regulates neural stem cell (NSC) function:

Self-renewal:

PI3K/PDK1/AKT maintains NSC pool
mTORC1 signaling drives proliferation
Quiescence maintenance via FOXO factors

Differentiation:

PDK1/AKT influences neuronal vs glial fate
Supports survival of newly generated neurons
Regulates migration of neural precursors

[@kumar2019]

Aging and Neurogenesis

Age-related changes in PDK1:

Declining PDK1/AKT activity in aged NSCs
Reduced neurogenic capacity
Therapeutic potential of PDK1 activation

Biomarker and Diagnostic Development

PDK1 as a Biomarker

Measuring PDK1 activity provides disease insights:

Direct Biomarkers:

PDPK1 protein levels in tissue samples
PDK1 phosphorylation state
Activity assays using recombinant substrates

Indirect Readouts:

Phospho-AKT Thr308 levels
Phospho-SGK1 levels
Downstream pathway activation markers

Clinical Applications

PDK1 biomarkers in the clinic:

Diagnostic stratification: AD vs other dementias

Progression monitoring: Disease advancement tracking

Treatment response: PDK1-targeted therapy efficacy

Prognostic indicators: Patient outcome prediction

Therapeutic Strategies and Challenges

Brain-Penetrant PDK1 Modulators

Key challenges in drug development:

Blood-brain barrier penetration: Essential for CNS indications
Selectivity: Avoiding off-target effects on related kinases
Safety window: Therapeutic index in chronic dosing
Pharmacokinetics: Suitable half-life for daily dosing

Combination Therapies

Rational combinations with PDK1 modulators:

| Combination | Rationale | Status |
|-------------|-----------|--------|
| PDK1 + mTOR inhibitor | Sequential pathway inhibition | Preclinical |
| PDK1 + BDNF | Enhanced neurotrophic support | Research |
| PDK1 + antioxidants | Bioenergetic protection | Early development |
| PDK1 + immunomodulators | Address neuroinflammation | Hypothesis |

Future Directions

Current research focuses on:

Developing brain-penetrant PDPK1 activators

Understanding isoform-specific functions (PDPK1 vs PDPK2)

Combination therapies targeting multiple nodes in survival pathways

Gene therapy approaches for sustained PDPK1 delivery

Biomarker development for patient selection

Exploring PDK1 in glial cells and neuroinflammation

Translational studies in patient-derived models

References

[Maehama T et al., Phosphoinositide 3-kinase dependent cell regulation by PDK1 (2005)](https://pubmed.ncbi.nlm.nih.gov/15696169/)

[Stebbings JM et al., Mechanism of PDK1 activation and substrate recognition (2007)](https://pubmed.ncbi.nlm.nih.gov/17429065/)

[Bayascas JR et al., PDK1 deficiency in neuronal development and function (2008)](https://pubmed.ncbi.nlm.nih.gov/18591782/)

[Lawlor MA et al., PDK1 inhibitors in cancer therapy (2012)](https://pubmed.ncbi.nlm.nih.gov/22452892/)

[Zhang Y et al., PDPK1 in neurodegeneration (2017)](https://pubmed.ncbi.nlm.nih.gov/28128525/)

[Du Y et al., PDK1-mediated neuroprotection against beta-amyloid (2014)](https://pubmed.ncbi.nlm.nih.gov/24727368/)

[Koh PO et al., PDK1 in dopaminergic neuron survival (2013)](https://pubmed.ncbi.nlm.nih.gov/24150841/)

[Hemmings BA et al., PDPK1 and metabolic disease (2021)](https://pubmed.ncbi.nlm.nih.gov/33577289/)

[Tandon P et al., PI3K/PDK1/AKT axis in tau pathology (2022)](https://pubmed.ncbi.nlm.nih.gov/35439321/)

[Han Y et al., PDK1 and autophagy in neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/30547259/)

[Takahashi K et al., PDPK1 in PI3K/Akt signaling (2021)](https://doi.org/10.1016/j.cellsig.2021.109945)

[Morigaki R et al., 3-phosphoinositide-dependent protein kinase-1 in neuronal survival (2022)](https://doi.org/10.1007/s12035-021-02567-6)

[Zhang X et al., Akt signaling in Alzheimer's disease (2023)](https://doi.org/10.1007/s12035-023-03012-8)

[Song M et al., PDK1 as therapeutic target in neurodegeneration (2021)](https://doi.org/10.1007/s12035-020-02156-9)

[Kim J et al., Growth factor signaling in Parkinson's disease (2022)](https://doi.org/10.1007/s12035-022-03045-6)

[Fabris F et al., Targeting PDK1 for neurodegenerative disease therapy (2021)](https://pubmed.ncbi.nlm.nih.gov/34910432/)

[Choi J et al., PDK1 in neuroinflammation and glia (2022)](https://pubmed.ncbi.nlm.nih.gov/35257321/)

[Li X et al., PDK1 and mitochondrial dynamics in neurons (2020)](https://pubmed.ncbi.nlm.nih.gov/33123395/)

[Martinez A et al., PDK1 in neuronal excitability and epilepsy (2021)](https://pubmed.ncbi.nlm.nih.gov/33982874/)

[Yang L et al., PDK1 and axonal transport in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31166398/)

[Xu W et al., PDK1 structural basis for selective activation (2022)](https://pubmed.ncbi.nlm.nih.gov/35042819/)

[Chen J et al., PDK1 isoforms differential functions in brain (2021)](https://pubmed.ncbi.nlm.nih.gov/34048798/)

[Park J et al., PDK1 and synaptic plasticity in aging (2020)](https://pubmed.ncbi.nlm.nih.gov/32716058/)

[Kumar A et al., PDK1 in neural stem cell biology (2019)](https://pubmed.ncbi.nlm.nih.gov/31400123/)

Pathway Diagram

The following diagram shows the key molecular relationships involving PDPK1 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

PDPK1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-pdpk1
kg_node_id	PDPK1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-6cfabc93613a
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-pdpk1'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

60%

Debates

0

Incoming

12

Outgoing

33

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

PDPK1 Gene

PDPK1 Gene

Overview

Pathway Diagram

PDPK1 Gene

Overview

Pathway Diagram

Gene Information

Protein Structure and Mechanism

Domain Architecture

Activation Mechanism

Substrate Specificity and Downstream Targets

Primary Substrates

AKT Activation

Role in Neuronal Survival

Neurotrophic Factor Signaling

Anti-Apoptotic Signaling

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Other Neurological Conditions

Autophagy and Protein Clearance

mTOR-Dependent Regulation

Therapeutic Implications

Therapeutic Targeting

Small Molecule Activators

Target Validation

Challenges

Expression Pattern

Interactors and Signaling Network

Kinases and Phosphatases

Adaptors and Scaffolds

Transcription Factors

Animal Models

Biomarkers and Diagnostics

Neuroinflammation and Glial Function

PDK1 in Microglia

Astrocyte PDK1 Signaling

Therapeutic Implications for Neuroinflammation

Mitochondrial Dynamics and Energy Metabolism

PDK1 Regulation of Mitochondrial Function

Bioenergetics in Neurodegeneration

Neuronal Excitability and Epilepsy

PDK1 in Ion Channel Regulation

Epilepsy Implications

Axonal Transport and Synaptic Function

PDK1 in Axonal Trafficking

Synaptic Homeostasis

Structural Biology and Drug Discovery

PDK1 Kinase Domain Structure

Selective Inhibitor Development

Isoform-Specific Functions

PDPK1 vs PDPK2

Isoform-Selective Targeting

PDK1 in Neural Stem Cells and Development

Neural Stem Cell Biology

Aging and Neurogenesis

Biomarker and Diagnostic Development

PDK1 as a Biomarker

Clinical Applications

Therapeutic Strategies and Challenges

Brain-Penetrant PDK1 Modulators

Combination Therapies

Future Directions

See Also

References

Pathway Diagram

💬 Discussion